Explore
Validate
Learn66316-1-Ig
antibody from Proteintech Group
Targeting: EPCAM
17-1A, 323/A3, CD326, CO-17A, EGP-2, EGP34, EGP40, Ep-CAM, ESA, GA733-2, HEA125, KS1/4, KSA, Ly74, M4S1, MH99, MIC18, MK-1, MOC31, TACST-1, TACSTD1, TROP1
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [18]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 66316-1-Ig - Provider product page
- Provider
- Proteintech Group
- Product name
- EPCAM antibody
- Antibody type
- Monoclonal
- Description
- KD/KO validated EPCAM antibody (Cat. #66316-1-Ig) is a mouse monoclonal antibody that shows reactivity with human and has been validated for the following applications: FC, IF, IHC, WB, ELISA.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 2A2D5
- Vial size
- 20ul, 150ul
Submitted references EEPD1 Inhibition Unleashes Antitumor Immunity in Colorectal Cancer by Activating the cGAS-STING Pathway.
Biomimetic nanoplatforms for combined DDR2 inhibition and photothermal therapy in dense breast cancer treatment.
Insights into the role of MSLN-positive circulating tumor cell as an auxiliary diagnostic biomarker in epithelial ovarian cancer.
Modeling hepatic steatosis with human adult stem cell-derived liver organoids.
Individualized drug screening in cholangiocarcinoma using organoid models and patient-derived tumor xenograft.
GTSE1-driven ZEB1 stabilization promotes pulmonary fibrosis through the epithelial-to-mesenchymal transition.
A Subpopulation of Luminal Progenitors Secretes Pleiotrophin to Promote Angiogenesis and Metastasis in Inflammatory Breast Cancer.
Immunohistochemistry identifies E-cadherin, N-cadherin and focal adhesion kinase (FAK) as predictors of stage I non-small cell lung carcinoma spread through the air spaces (STAS), and the combinations as prognostic factors.
Downregulation of NEBL promotes migration and invasion of clear cell renal cell carcinoma by inducing epithelial-mesenchymal transition.
Deciphering the cellular landscape and potential targets of nasopharyngeal and oral cancers using single-cell RNA sequencing.
Photo-functionalized TiO(2) film for facile immobilization of EpCAM antibodies and efficient enrichment of circulating tumor cells.
NDRG1 facilitates self-renewal of liver cancer stem cells by preventing EpCAM ubiquitination.
MCM2 promotes the stemness and sorafenib resistance of hepatocellular carcinoma cells via hippo signaling.
Multi-modal imaging probe for EpCAM overexpressed in breast cancer.
Spherical nucleic acids-based cascade signal amplification for highly sensitive detection of exosomes.
Tumor cell membrane-based peptide delivery system targeting the tumor microenvironment for cancer immunotherapy and diagnosis.
miR-552 Regulates Liver Tumor-Initiating Cell Expansion and Sorafenib Resistance.
Mutations in the coat complex II component SEC23B promote colorectal cancer metastasis.
Huo L, Wu C, Li X, Ma C, Huang J, Chen Z, He W, Tao T, Zhang W
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026 Mar 30;:e22826
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026 Mar 30;:e22826
Biomimetic nanoplatforms for combined DDR2 inhibition and photothermal therapy in dense breast cancer treatment.
Chen Y, Yu Y, Fan Y, Lu W, Wei Y, Wu J, Ruan B, Wan Z, Zhao Y, Xie K, Jie W, Zheng S
Biomaterials 2026 Jan;324:123497
Biomaterials 2026 Jan;324:123497
Insights into the role of MSLN-positive circulating tumor cell as an auxiliary diagnostic biomarker in epithelial ovarian cancer.
Xu H, Wang M, Wu S, Li Q, Wang J, Zhang S, Liu Q, Wang M, Li R, Hu Z, Liu Y, Yang Z
Frontiers in oncology 2025;15:1563095
Frontiers in oncology 2025;15:1563095
Modeling hepatic steatosis with human adult stem cell-derived liver organoids.
Zhu L, Liu S, Wang Z, Yang Y, Han P, Tong W, Zhao T, Wang L, Cui T, Yang L, Zhang Y
iScience 2025 May 16;28(5):112344
iScience 2025 May 16;28(5):112344
Individualized drug screening in cholangiocarcinoma using organoid models and patient-derived tumor xenograft.
Han P, Zhu L, Tong W, Liu S, Xu Y, Wang L, Wang T, Zhao T, Miao Y, Chi H, Cui T, Wang Z, Yang L, Zhang Y
BMC cancer 2025 Dec 31;26(1):173
BMC cancer 2025 Dec 31;26(1):173
GTSE1-driven ZEB1 stabilization promotes pulmonary fibrosis through the epithelial-to-mesenchymal transition.
Jin H, Park SY, Lee JE, Park H, Jeong M, Lee H, Cho J, Lee YS
Molecular therapy : the journal of the American Society of Gene Therapy 2024 Nov 6;32(11):4138-4157
Molecular therapy : the journal of the American Society of Gene Therapy 2024 Nov 6;32(11):4138-4157
A Subpopulation of Luminal Progenitors Secretes Pleiotrophin to Promote Angiogenesis and Metastasis in Inflammatory Breast Cancer.
Zhang M, Zhou K, Wang Z, Liu T, Stevens LE, Lynce F, Chen WY, Peng S, Xie Y, Zhai D, Chen Q, Shi Y, Shi H, Yuan Z, Li X, Xu J, Cai Z, Guo J, Shao N, Lin Y
Cancer research 2024 Jun 4;84(11):1781-1798
Cancer research 2024 Jun 4;84(11):1781-1798
Immunohistochemistry identifies E-cadherin, N-cadherin and focal adhesion kinase (FAK) as predictors of stage I non-small cell lung carcinoma spread through the air spaces (STAS), and the combinations as prognostic factors.
Meng Y, Wang Y, Liu L, Wu R, Zhang Q, Chen Z, Yao Y, Li X, Gong Y, Li H, Wang Z, Liu H
Translational lung cancer research 2024 Jul 30;13(7):1450-1462
Translational lung cancer research 2024 Jul 30;13(7):1450-1462
Downregulation of NEBL promotes migration and invasion of clear cell renal cell carcinoma by inducing epithelial-mesenchymal transition.
Zhao R, Liang Z, Chu J, Zheng Q, Zhao J, Tang S, Chen Q, Huang Y, Zhou X, Pan X
Pathology, research and practice 2024 Feb;254:155068
Pathology, research and practice 2024 Feb;254:155068
Deciphering the cellular landscape and potential targets of nasopharyngeal and oral cancers using single-cell RNA sequencing.
Zhang Y, Qin X, Lou W, Wang L, Lu W, Gao C, Hu S
Cell biology international 2024 Dec;48(12):1849-1861
Cell biology international 2024 Dec;48(12):1849-1861
Photo-functionalized TiO(2) film for facile immobilization of EpCAM antibodies and efficient enrichment of circulating tumor cells.
Deng H, Liu X, Chen J, He Y, Lin L, Liu X, Chen J, Liu X
Frontiers in pharmacology 2023;14:1126602
Frontiers in pharmacology 2023;14:1126602
NDRG1 facilitates self-renewal of liver cancer stem cells by preventing EpCAM ubiquitination.
Cheng Q, Ning S, Zhu L, Zhang C, Jiang S, Hao Y, Zhu J
British journal of cancer 2023 Aug;129(2):237-248
British journal of cancer 2023 Aug;129(2):237-248
MCM2 promotes the stemness and sorafenib resistance of hepatocellular carcinoma cells via hippo signaling.
Zhou X, Luo J, Xie H, Wei Z, Li T, Liu J, Liao X, Zhu G, Peng T
Cell death discovery 2022 Oct 15;8(1):418
Cell death discovery 2022 Oct 15;8(1):418
Multi-modal imaging probe for EpCAM overexpressed in breast cancer.
Dai Y, Tang Y, Huang W, Zhao Y, Gao X, Gu Y
Talanta 2022 Dec 1;250:123715
Talanta 2022 Dec 1;250:123715
Spherical nucleic acids-based cascade signal amplification for highly sensitive detection of exosomes.
Wang L, Deng Y, Wei J, Huang Y, Wang Z, Li G
Biosensors & bioelectronics 2021 Nov 1;191:113465
Biosensors & bioelectronics 2021 Nov 1;191:113465
Tumor cell membrane-based peptide delivery system targeting the tumor microenvironment for cancer immunotherapy and diagnosis.
Meng X, Wang J, Zhou J, Tian Q, Qie B, Zhou G, Duan W, Zhu Y
Acta biomaterialia 2021 Jun;127:266-275
Acta biomaterialia 2021 Jun;127:266-275
miR-552 Regulates Liver Tumor-Initiating Cell Expansion and Sorafenib Resistance.
Han T, Zhang Y, Yang X, Han L, Li H, Chen T, Zheng Z
Molecular therapy. Nucleic acids 2020 Mar 6;19:1073-1085
Molecular therapy. Nucleic acids 2020 Mar 6;19:1073-1085
Mutations in the coat complex II component SEC23B promote colorectal cancer metastasis.
Yang C, Chen N, Li X, Lu D, Hou Z, Li Y, Jin Y, Gu J, Yin Y
Cell death & disease 2020 Mar 2;11(3):157
Cell death & disease 2020 Mar 2;11(3):157
No comments: Submit comment
No validations: Submit validation data